Study of Amrubicin With or Without Herceptin in Patients With Metastatic Breast Cancer
Clinical trial NCT00380835 · WITHDRAWN
Trial details
- NCT number
- NCT00380835
- Sponsor
- Celgene Corporation
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Enrollment
- 66
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.